As a result, the decreased proliferation (Figure 6C-D) and migration (Figure 6E) abilities of Mia CaPa-2 and SW-1990 cells brought by TMEM105 knockdown could be reversed by c-MYC overexpression. The gene discussed is TMEM105; the disease is episodic ataxia type 2.